Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−28.2 SEK
−3.85 B SEK
3.51 B SEK
69.03 M
About VITROLIFE AB
Sector
Industry
CEO
Bronwyn Brophy
Website
Headquarters
Gothenburg
Founded
1989
ISIN
SE0011205202
FIGI
BBG000DMWXX2
Vitrolife AB develops, produces, and markets products for creating, prolonging, and improving life. It focuses on fertility treatments, cell therapy and tissue engineering, and organ transplantation systems. The company was founded in 1994 and is headquartered in Gothenburg, Sweden.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VITR is 226.8 SEK — it has increased by 2.35% in the past 24 hours. Watch VITROLIFE AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange VITROLIFE AB stocks are traded under the ticker VITR.
VITR stock has risen by 2.81% compared to the previous week, the month change is a −6.21% fall, over the last year VITROLIFE AB has showed a 24.55% increase.
We've gathered analysts' opinions on VITROLIFE AB future price: according to them, VITR price has a max estimate of 280.00 SEK and a min estimate of 260.00 SEK. Watch VITR chart and read a more detailed VITROLIFE AB stock forecast: see what analysts think of VITROLIFE AB and suggest that you do with its stocks.
VITR reached its all-time high on Oct 29, 2021 with the price of 585.0 SEK, and its all-time low was 1.6 SEK and was reached on Apr 24, 2003. View more price dynamics on VITR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VITR stock is 2.86% volatile and has beta coefficient of 0.48. Track VITROLIFE AB stock price on the chart and check out the list of the most volatile stocks — is VITROLIFE AB there?
Today VITROLIFE AB has the market capitalization of 29.98 B, it has decreased by −3.45% over the last week.
Yes, you can track VITROLIFE AB financials in yearly and quarterly reports right on TradingView.
VITROLIFE AB is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
VITR earnings for the last quarter are 0.85 SEK per share, whereas the estimation was 1.07 SEK resulting in a −20.31% surprise. The estimated earnings for the next quarter are 1.20 SEK per share. See more details about VITROLIFE AB earnings.
VITROLIFE AB revenue for the last quarter amounts to 867.00 M SEK, despite the estimated figure of 902.60 M SEK. In the next quarter, revenue is expected to reach 945.94 M SEK.
VITR net income for the last quarter is 116.00 M SEK, while the quarter before that showed 143.00 M SEK of net income which accounts for −18.88% change. Track more VITROLIFE AB financial stats to get the full picture.
Yes, VITR dividends are paid annually. The last dividend per share was 1.00 SEK. As of today, Dividend Yield (TTM)% is 0.45%. Tracking VITROLIFE AB dividends might help you take more informed decisions.
As of Nov 25, 2024, the company has 1.12 K employees. See our rating of the largest employees — is VITROLIFE AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VITROLIFE AB EBITDA is 1.22 B SEK, and current EBITDA margin is 32.97%. See more stats in VITROLIFE AB financial statements.
Like other stocks, VITR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VITROLIFE AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VITROLIFE AB technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VITROLIFE AB stock shows the buy signal. See more of VITROLIFE AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.